Astellas Pharma US
Astellas Pharma US, Inc.
2375 Waterview Drive
Northbrook, IL 60062
Phone: (800) 727-7003Website: https://www.astellas.com/us/Careers: astellascareers.jobsPatient Assistance Program: astellaspharmasupportsolutions.com...
Latest news
- U.S. FDA Approves Expanded Label for Astellas' Izervay (avacincaptad pegol intravitreal solution) for Geographic Atrophy
12 February 2025 - FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer
21 October 2024 - FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause
12 September 2024 - U.S. FDA Acknowledges Astellas' Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date
30 May 2024 - Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
26 January 2024 - Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
8 January 2024 - Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
15 December 2023 - FDA Approves Expanded Use of Cresemba (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
8 December 2023 - Pfizer and Astellas' Xtandi Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
16 November 2023 - FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy
5 August 2023
Drugs Associated with Astellas Pharma US, Inc.
Astellas Pharma US, Inc. manufactures, markets and/or distributes more than 15 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
|
Astagraf XL
Generic name: tacrolimus Drug class: calcineurin inhibitors |
||
|
Cresemba
Generic name: isavuconazonium Drug class: azole antifungals |
2 reviews | 4.7 / 10 |
|
Izervay
Generic name: avacincaptad pegol Drug class: anti-angiogenic ophthalmic agents |
3 reviews | 9.0 / 10 |
|
Lexiscan
Generic name: regadenoson Drug class: cardiac stressing agents |
36 reviews | 6.0 / 10 |
|
Mycamine
Generic name: micafungin Drug class: echinocandins |
||
|
Myrbetriq
Generic name: mirabegron Drug class: urinary antispasmodics |
276 reviews | 4.8 / 10 |
|
Padcev
Generic name: enfortumab vedotin Drug class: miscellaneous antineoplastics |
2 reviews | 1.0 / 10 |
|
Prograf
Generic name: tacrolimus Drug class: calcineurin inhibitors |
28 reviews | 8.1 / 10 |
|
Veozah
Generic name: fezolinetant Drug class: miscellaneous central nervous system agents |
40 reviews | 7.7 / 10 |
|
VESIcare
Generic name: solifenacin Drug class: urinary antispasmodics |
142 reviews | 5.6 / 10 |
|
VESIcare LS
Generic name: solifenacin Drug class: urinary antispasmodics |
||
|
Vyloy
Generic name: zolbetuximab Drug class: miscellaneous antineoplastics |
||
|
Xospata
Generic name: gilteritinib Drug class: multikinase inhibitors |
1 review | 8.0 / 10 |
|
Xtandi
Generic name: enzalutamide Drug class: antiandrogens, hormones/antineoplastics |
21 reviews | 5.8 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||